Mitoxantrone

colony stimulating factor 3 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 15555260 [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies]. 2004 Aug 1
2 12531794 CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. 2003 May 15 2
3 11792410 Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas. 2002 Mar 2
4 9923546 Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy. 1999 3
5 10071277 Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer. 1999 Mar 1
6 10424407 Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study. 1999 Mar 2
7 9692399 Granulocyte colony-stimulating factor (G-CSF) mediated mobilization of leukemic cells in Philadelphia chromosome positive acute lymphoblastic leukemia expressing myeloid antigens (my+Ph+ALL). 1998 Aug 1
8 9797080 Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group. 1998 Sep 1
9 9028308 Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. 1997 Feb 1 2
10 9095330 Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group. 1997 Mar 1
11 8599980 Effect of cytokines on the toxicity of cytostatic drugs on leukemic cells in vitro and in vivo. 1996 Jan-Feb 1
12 8640159 High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. 1996 Feb 1
13 7524607 Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer. 1994 Nov 1
14 7526508 Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study. 1994 Aug 31 1
15 7530472 Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer. 1994 1